Publications

2023

Zafar, R., Siegel, M., Harding, R., Barba, T., Agnorelli, C., Suseelan, S., ... & Erritzoe, D. (2023). Psychedelic therapy in the treatment of addiction: the past, present and future. Frontiers in Psychiatry, 14, 1183740.

McCrone, P., Fisher, H., Knight, C., Harding, R., Schlag, A. K., Nutt, D. J., & Neill, J. C. (2023). Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model. Psychological Medicine, 1-8.

Azmoodeh, K., Thomas, E., & Kamboj, S. K. (2023). Meditation trips: A thematic analysis of the combined naturalistic use of psychedelics with meditation practices. Experimental and Clinical Psychopharmacology, 31(3), 756.

Dougherty, R. F., Clarke, P., Atli, M., Kuc, J., Schlosser, D., Dunlop, B. W., ... & Ryslik, G. A. (2023). Psilocybin therapy for treatment-resistant depression: prediction of clinical outcome by natural language processing. Psychopharmacology, 1-9.

McAlpine, R., Blackburne, G., & Kamboj, S. (2023). Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’.

Cooper, G., Blackburne G., Dekker, T., Das, R., Skipper, J. (2023) When the present gets remembered: Sensory regions communicate with the brain over the longest timescales.

Evans, J., Robinson, O., Ketzitzidou-Argyri, E., Suseelan, S., Murphy-Beiner, A., & McAlpine, R. (2023). Extended Difficulties Following the Use of Psychedelic Drugs: A Mixed Methods Study.

Kuc, J., Lametti, D. R., Camburu, O. M., & Skipper, J. I. (2023). The Psychological Benefits of Journaling and Feedback through a Large Language Model-Driven Conversational Bot.

2022

Wall, M. B., Harding, R., Zafar, R., Rabiner, E. A., Nutt, D. J., & Erritzoe, D. (2022). Neuroimaging in psychedelic drug development: Past, present, and future.